Detalhe da pesquisa
1.
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
N Engl J Med
; 386(19): 1793-1803, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544387
2.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Clin Infect Dis
; 76(5): 861-870, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259527
3.
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.
Clin Infect Dis
; 77(7): 991-1009, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207617
4.
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
J Antimicrob Chemother
; 78(9): 2361-2365, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539492
5.
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe.
HIV Med
; 23(6): 684-692, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882940
6.
Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir: a DUALIS sub-study.
AIDS Care
; 34(6): 698-707, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896276
7.
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials.
Clin Infect Dis
; 73(8): 1440-1451, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33987636
8.
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV.
J Antimicrob Chemother
; 76(9): 2380-2393, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120186
9.
Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy.
AIDS Care
; 33(4): 453-461, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106695
10.
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance.
AIDS Res Ther
; 18(1): 58, 2021 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496848
11.
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.
Clin Infect Dis
; 71(6): 1379-1389, 2020 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606734
12.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Lancet
; 393(10189): 2428-2438, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056293
13.
Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017.
Infection
; 48(5): 723-733, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613529
14.
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study.
Clin Infect Dis
; 68(4): 597-606, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29912307
15.
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
Lancet
; 390(10107): 2073-2082, 2017 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28867499
16.
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
Lancet
; 390(10101): 1499-1510, 2017 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750935
17.
Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.
Clin Infect Dis
; 64(10): 1413-1421, 2017 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329090
18.
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.
J Hepatol
; 66(2): 282-287, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650285
19.
The "Choosing Wisely" initiative in infectious diseases.
Infection
; 45(3): 263-268, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28290130
20.
HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans.
Infection
; 44(2): 151-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26471511